| Crosslinked sodium hyaluronate implant in deep sclerectomy for the surgical treatment of glaucoma. | |
| | |
MedLine Citation:
|
PMID: 22167544 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Purpose. To evaluate the efficacy and safety profile of a new crosslinked sodium hyaluronate drainage implant in nonpenetrating glaucoma surgery. Methods. From July 2008 until January 2010, 55 eyes from 55 patients with glaucoma were operated upon. After a standard deep sclerectomy was performed, a crosslinked sodium hyaluronate (HEALAflow®) was injected under the superficial scleral flap and underneath the conjunctiva. The main outcomes measured were mean intraocular pressure (IOP), mean number of antiglaucoma medications, presence of postoperative complications, and clinical aspect of the filtering bleb. Results. For the 55 eyes, the mean follow-up was 12.0±5.1 months, the mean preoperative IOP was 21.6±7.2 mmHg, and the mean number of antiglaucoma medications before surgery was 2.4±1.2. At final follow-up visits, the mean IOP went down to 11.5±3.0 mmHg; the mean number of antiglaucoma medications was reduced to 0.5±0.9. The filtering bleb was visible on 49 eyes (89%). There were 5 hypotonies (IOP < 6 mmHg) and 3 iris incarcerations. Complete success rate (IOP =18 mmHg without antiglaucoma medication) was 70% and the overall success rate (IOP =18 mmHg with and without antiglaucoma medication) was 91%. Conclusions. The slow resorbable highly crosslinked sodium hyaluronate drainage implant fills up the intrascleral and subconjunctival space, preventing postoperative scarring and fibrosis of the filtering site and helping to maintain a functional filtration after nonpenetrating glaucoma surgery. The IOP was significantly lowered with few numbers of postoperative complications and less medication. |
| | |
Authors:
|
Sylvain Roy; Huyen Do Thi; Michael Feusier; André Mermoud |
Related Documents
:
|
20958854 - Stimulant formulation and motivation for nonmedical use of prescription attention-defic... 7910754 - Effects of medication history on midlatency auditory evoked responses in schizophrenia. 16710714 - Evaluation of factors influencing medication compliance in inpatient treatment of psych... 15060224 - National institute of mental health multimodal treatment study of adhd follow-up: 24-mo... 9025224 - An adjustable table tennis bat and grip system for tetraplegics. 21263064 - Expression of patients' and providers' identities during the medical interview. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European journal of ophthalmology Volume: 22 ISSN: 1724-6016 ISO Abbreviation: Eur J Ophthalmol Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2011-12-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9110772 Medline TA: Eur J Ophthalmol Country: Italy |
Other Details:
|
Languages: eng Pagination: 70-6 Citation Subset: IM |
Affiliation:
|
Glaucoma Center, Montchoisi Clinic Lausanne, Lausanne - Switzerland; and Swiss Federal Institute of Technology, Lausanne - Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Topographic differences between large and normal optic discs: a confocal scanning laser ophthalmosco...
Next Document: The impact of intraocular pressure reduction on retrobulbar hemodynamic parameters in patients with ...